The Joint Corp. (JYNT)
The Joint Corp. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
The Joint Corp. (JYNT) is a Medical - Care Facilities company based in US with a market capitalization of $128.3M. Revenue grew 5.2% year-over-year and the company generated $334.7K in free cash flow. This page tracks JYNT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 443 employees · IPO Nov 11, 2014
Valuation
Valuation & price
$8.23 · as of May 17, 2026 · -31.4% vs 52w high
42.8
P/E ratio
Latest-FY diluted EPS
8.52
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$128.3M
Market cap
5.2%
Revenue growth (YoY)
79.5%
Gross margin
$334.7K
Free cash flow (USD)
-$21.6M
Net debt
Net cash position
1.4%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 8, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is The Joint Corp.'s market cap?
The Joint Corp. (JYNT) has a market capitalization of $128.3M.
What is JYNT's P/E ratio?
JYNT trades at a price-to-earnings ratio of 42.8, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is JYNT's price-to-book (P/B) ratio?
JYNT trades at 8.52 times book value per share.
Are insiders buying JYNT stock?
SEC Form 4 filings show no open-market insider buys at The Joint Corp. in the last 90 days (0 sells).
Same arena
Related companies in Medical - Care Facilities
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.